The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway

Mustard NPR1, a mammalian IκB homologue inhibits NF-κB activation in human GBM cell lines

(2009) Divya Kesanakurti et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model

(2009) Chung Kwon Kim et al.   CANCER LETTERS

Genetic alterations and signaling pathways in the evolution of gliomas

(2009) Hiroko Ohgaki et al.   CANCER SCIENCE

Aggravated Endoplasmic Reticulum Stress as a Basis for Enhanced Glioblastoma Cell Killing by Bortezomib in Combination with Celecoxib or Its Non-Coxib Analogue, 2,5-Dimethyl-Celecoxib

(2008) A. Kardosh et al.   CANCER RESEARCH

Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells

(2008) Huei-Fang Liu et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastoma

(2008) Stuart A. Grossman et al.   NEURO-ONCOLOGY

Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults

(2008) Santosh Kesari et al.   NEURO-ONCOLOGY

TRAIL-mediated apoptosis in malignant glioma cells is augmented by celecoxib through proteasomal degradation of survivin

(2008) T. Gaiser et al.   NEUROSCIENCE LETTERS